These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2908225)

  • 1. Structure activity relationships of anxiolytics.
    Wong MG
    Drug Des Deliv; 1988 Jul; 3(1):15-33. PubMed ID: 2908225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Benzodiazepines, receptor affinity, their endogenous ligands and the modeling of new psychotropic preparations].
    Voronina TA; Andronati SA; Akhundov RA; Chepelev VM
    Vestn Akad Med Nauk SSSR; 1984; (11):13-20. PubMed ID: 6152097
    [No Abstract]   [Full Text] [Related]  

  • 3. Discovery of anxiolytic 2-ferrocenyl-1,3-thiazolidin-4-ones exerting GABAA receptor interaction via the benzodiazepine-binding site.
    Pejović A; Denić MS; Stevanović D; Damljanović I; Vukićević M; Kostova K; Tavlinova-Kirilova M; Randjelović P; Stojanović NM; Bogdanović GA; Blagojević P; D'hooghe M; Radulović NS; Vukićević RD
    Eur J Med Chem; 2014 Aug; 83():57-73. PubMed ID: 24950490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure--activity relationships of eseroline and morphine: ab initio quantum-chemical study of the electrostatic potential and of the interaction energy with water.
    Agresti A; Buffoni F; Kaufman JJ; Petrongolo C
    Mol Pharmacol; 1980 Nov; 18(3):461-7. PubMed ID: 7464812
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure-activity relationships in thienodiazepine and benzodiazepine derivatives.
    Chimirri A; Gitto R; Grasso S; Zappalà M; De Sarro A; Battista De Sarro G
    Farmaco; 1994 Mar; 49(3):193-6. PubMed ID: 8043171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GABA-ergic system: a locus of benzodiazepine action.
    Tallman JF; Gallager DW
    Annu Rev Neurosci; 1985; 8():21-44. PubMed ID: 2858999
    [No Abstract]   [Full Text] [Related]  

  • 7. Conformational shifts at the benzodiazepine receptor related to the binding of agonists antagonists and inverse agonists.
    Fryer RI; Cook C; Gilman NW; Walser A
    Life Sci; 1986 Nov; 39(21):1947-57. PubMed ID: 3023774
    [No Abstract]   [Full Text] [Related]  

  • 8. Analytical profile of metaclazepam.
    Althaus W; Block J; Förster A; Kühnhold M; Meister D; Wischniewski M
    Arzneimittelforschung; 1986 Sep; 36(9):1302-6. PubMed ID: 3790179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling of alpha 2-adrenergic ligands.
    Rouvinen J; Hoffrén AM; Karjalainen A; Pakkanen TA
    Drug Des Discov; 1993; 10(4):285-95. PubMed ID: 7908541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of closely related benzodiazepines.
    Curry SH; Whelpton R
    Br J Clin Pharmacol; 1979; 8(1):15S-21S. PubMed ID: 41538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sedative and anxiolytic potency of benzodiazepines: some structure-activity relationships.
    Krsiak M; Sulcová A
    Act Nerv Super (Praha); 1989 Apr; 31(1):59-61. PubMed ID: 2571229
    [No Abstract]   [Full Text] [Related]  

  • 12. Distance geometry analysis of the benzodiazepine binding site.
    Crippen GM
    Mol Pharmacol; 1982 Jul; 22(1):11-9. PubMed ID: 6289067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous ligands of benzodiazepine binding site have inverse agonistic properties.
    Sliva J; Hess L; Votava M; Malek J
    Med Hypotheses; 2013 Dec; 81(6):1075-7. PubMed ID: 24183322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buspirone, a novel nonbenzodiazepine anxiolytic.
    Kastenholz KV; Crismon ML
    Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buspirone: chemistry, pharmacology, and behavior.
    Skolnick P; Paul SM
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):40-4. PubMed ID: 6130072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of drugs by polarographic methods, XXX: Electrochemical behavior of metaclazepam[7-bromo-5-(2-chlorophenyl)-2,3-dihydro-2-(methoxyme thyl)- 1- methyl-1H-1,4-benzodiazepine] and assay of its formulations.
    Oelschläger H; Ellaithy MM
    Arch Pharm (Weinheim); 1987 Aug; 320(8):711-8. PubMed ID: 2890336
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacologic effects of tofizopam (Grandaxin)].
    Petócz L
    Acta Pharm Hung; 1993 Mar; 63(2):79-82. PubMed ID: 8100112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of benzodiazepines and non-benzodiazepine anxiolytics on biochemical and behavioral tests predictive of anxiolytic activity.
    Malick JB; Enna SJ
    Commun Psychopharmacol; 1979; 3(4):245-52. PubMed ID: 43210
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of conformationally restricted 4-piperazinyl-10H-thienobenzodiazepine neuroleptics on central dopaminergic and cholinergic systems.
    Chakrabarti JK; Hotten TM; Morgan SE; Pullar IA; Rackham DM; Risius FC; Wedley S; Chaney MO; Jones ND
    J Med Chem; 1982 Oct; 25(10):1133-40. PubMed ID: 6128416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor.
    Langen B; Egerland U; Bernöster K; Dost R; Unverferth K; Rundfeldt C
    J Pharmacol Exp Ther; 2005 Aug; 314(2):717-24. PubMed ID: 15860576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.